Avacta Group plc (GB:AVCT) has released an update.
Avacta Group plc, a life sciences company focusing on cancer treatments and diagnostics, has appointed Shaun Chilton as the new Non-Executive Chairman, succeeding Eliot Forster. Chilton, who has a notable history of leading pharmaceutical companies and driving business growth, aims to support Avacta’s clinical development of their proprietary pre|CISION™ platform. The company is transitioning towards a therapeutics-focused organization, with ongoing board evolution to bolster its strategic objectives.
For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.
